Darzalex
Darzalex | |
---|---|
Term | Darzalex |
Short definition | Darzalex - (pronounced) (DAR-number-lex) medicine used alone or with other medicines to treat adults with multiple myeloma. It is used in patients whose cancer has been newly diagnosed and who may or may not be treated with autologous stem cell transplantation. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Darzalex - (pronounced) (DAR-number-lex) medicine used alone or with other medicines to treat adults with multiple myeloma. It is used in patients whose cancer has been newly diagnosed and who may or may not be treated with autologous stem cell transplantation. Darzalex is also used in patients whose cancer has come back or has not improved after treatment with one or more anticancer therapies. It is also being studied in the treatment of other types of cancer. Darzalex attaches to a protein called CD38, which is found on some types of immune cells and cancer cells, including myeloma cells. Darzalex can block CD38 and help the immune system kill cancer cells. It's a type of monoclonal antibody. Also called daratumumab
External links
- Medical encyclopedia article on Darzalex
- Wikipedia's article - Darzalex
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski